(Q34278856)

1 August 2017

1 reference

title

Differentiation of the low-molecular-weight heparins (English)

1 reference

1 August 2017

E Racine

1

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

21

1 reference

1 August 2017

issue

6 Pt 2

1 reference

1 August 2017

page(s)

62S-70S; discussion 71S-72S

1 reference

Low-molecular-weight heparins

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Standardization of prothrombin time for laboratory control of oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Comparative pharmacokinetics of LMWHs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Antithrombotic therapy for venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

From the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.8.62S.34594

10.1592/PHCO.21.8.62S.34594

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference